美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Defiance Daily Target 2X Long MRNA ETF

80.98

-3.7400-4.41%

盤後：81.300.3200+0.40%19:30 EDT

成交量：10.67萬

成交額：862.32萬

市值：2,510.38萬

市盈率：- -

高：86.50

開：83.55

低：78.31

收：84.72

52周最高：143.84

52周最低：14.95

股本：31.00萬

流通股本：31.00萬

量比：0.55

換手率：34.43%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

阿斯利康股價盤後跌超2%，因其三期臨床試驗結果令人失望。

Moderna Inc(MRNA)股票9月11日盤中上漲8.63%：關鍵驅動因素揭曉

TradingKey中文

沃森生物(300142.SZ)子公司新型冠狀病毒mRNA疫苗獲得藥品註冊證書

沃森生物：玉溪沃森mRNA疫苗獲批上市許可，適用18周歲以上

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/MRNX"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MRNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long MRNA ETF","latestPrice":80.98,"timestamp":1789502400000,"preClose":84.72,"halted":0,"volume":106729,"hourTrading":{"tag":"盘后","latestPrice":81.3,"preClose":80.98,"latestTime":"19:30 EDT","volume":262,"amount":21229.71852,"timestamp":1789515006542,"change":0.32,"changeRate":0.003952,"amplitude":0.023427},"delay":0,"changeRate":-0.04414542020774309,"floatShares":310000,"shares":310000,"eps":0,"marketStatus":"盤後交易","change":-3.74,"latestTime":"09-15 19:32:14 EDT","open":83.55,"high":86.5,"low":78.312,"amount":8623183.963415,"amplitude":0.096648,"askPrice":82.38,"askSize":40,"bidPrice":78.78,"bidSize":1,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":84.72,"sharesOutstanding":30000,"nav":81.58,"aum":25289800,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":82.44,"preClose":84.72,"latestTime":"09:25 EDT","volume":260,"amount":21575.661900000003,"timestamp":1789478724165,"change":-2.28,"changeRate":-0.026912,"amplitude":0.017587},"postHourTrading":{"tag":"盘后","latestPrice":81.3,"preClose":80.98,"latestTime":"19:30 EDT","volume":262,"amount":21229.71852,"timestamp":1789515006542,"change":0.32,"changeRate":0.003952,"amplitude":0.023427},"volumeRatio":0.554572,"impliedVol":1.3348,"impliedVolPercentile":0.3571},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","floatShares":310000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.554572,"shares":310000,"dividePrice":0,"high":86.5,"amplitude":0.096648,"preClose":84.72,"low":78.312,"week52Low":14.95,"pbRate":"--","week52High":143.84,"institutionHeld":0,"latestPrice":80.98,"committee":-0.95122,"eps":0,"divideRate":0,"volume":106729,"delay":0,"ttmEps":0,"open":83.55,"prevYearClose":20.61,"prevWeekClose":81.41,"prevMonthClose":79.5,"prevQuarterClose":42.65,"fiveDayClose":78.06,"twentyDayClose":32.8824,"sixtyDayClose":36.565},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MRNX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MRNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MRNX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MRNX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666571008","title":"阿斯利康股價盤後跌超2%，因其三期臨床試驗結果令人失望。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571008","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666571008?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 04:23","pubTimestamp":1789158183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FBT","HELX","IDNA","RXL","LU2272731600.USD","AZNH","BME","IEHS","BK4585","LU2473716301.USD","IEIH","PPH","LU2272731782.SGD","XBIX","LU2322448791.USD","SYNB","LU2322448957.HKD","LU1992135472.HKD","PJP","MRNY","LU2272731865.HKD","MEDI","IBRN","RSPH","PBE","TMED","GNOM","PBPH","BBP","IBB","BBH","CANC","BK4588","BIB","XPH","BIOY","FTXH","MRNX","IE00B5TLWC47.USD","SBIO","LFSC","PSCH","LU1992135399.USD","WDNA","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666657657","title":"Moderna Inc(MRNA)股票9月11日盤中上漲8.63%：關鍵驅動因素揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=2666657657","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666657657?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 01:16","pubTimestamp":1789146984,"startTime":"0","endTime":"0","summary":"• 受机构买盘重新涌入及盘整巩固的推动，莫德纳出现上行波动。\n• intismeran autogene 的 3 期临床试验结果验证了其肿瘤学平台。\n• 最新年度营收为 19.4 亿美元，净亏损为 28.2 亿美元。","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262164048-market-movers-mrna-20260911","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","BK4534","BK4588","MRNY","BK4585","GNOM","BK4532","WDNA","BK4533","BK4548","MRNA","LGHT","IDNA","MRNX","BK4501","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666596397","title":"沃森生物(300142.SZ)子公司新型冠狀病毒mRNA疫苗獲得藥品註冊證書","url":"https://stock-news.laohu8.com/highlight/detail?id=2666596397","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666596397?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 20:57","pubTimestamp":1789045066,"startTime":"0","endTime":"0","summary":"智通财经APP讯，沃森生物 发布公告，公司全资子公司玉溪沃森生物技术有限公司于2026年9月10日收到由国家药品监督管理局批准颁发的“新型冠状病毒mRNA疫苗”《药品注册证书》。据悉，该疫苗是公司基于mRNA平台技术策略迭代开发的第三代新冠病毒mRNA疫苗。目前，mRNA技术在全球正应用于生物医药前沿科技创新研发及应用领域。自2020年以来，公司对mRNA技术持续加大研发投入，建立了国内领先的mRNA技术和产业化平台。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0070","MRNY","BK0077","BK0046","MRNX","300142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666989385","title":"沃森生物：玉溪沃森mRNA疫苗獲批上市許可，適用18周歲以上","url":"https://stock-news.laohu8.com/highlight/detail?id=2666989385","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666989385?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 19:48","pubTimestamp":1789040889,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MRNY","IPOS","MRNX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MRNX\",params:#limit:6,delay:false,,,undefined,":[]}}